                         SEQUENCE LISTING

<110>  Denovo Biopharma (Hangzhou) Ltd. Co.
       Denovo Biopharma LLC
 
<120>  COMBINATION OF ENZASTAURIN AND INHIBITORS OF BTK AND USES THEREOF

<130>  4594-2000641

<150>  PCT/CN2018/105217
<151>  2018-09-12


<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  1
tccaccagtt tgaatggtca at                                                22


<210>  2
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  2
cgcagagggt tgtattggtt c                                                 21


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  3
gcaccgtcaa ggctgagaac                                                   20


<210>  4
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  4
tggtgaagac gccagtgga                                                    19


<210>  5
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  5
tgccaacatc caggacaaca t                                                 21


